Correlation Between Gilead Sciences and Evolus
Can any of the company-specific risk be diversified away by investing in both Gilead Sciences and Evolus at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Gilead Sciences and Evolus into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Gilead Sciences and Evolus Inc, you can compare the effects of market volatilities on Gilead Sciences and Evolus and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Gilead Sciences with a short position of Evolus. Check out your portfolio center. Please also check ongoing floating volatility patterns of Gilead Sciences and Evolus.
Diversification Opportunities for Gilead Sciences and Evolus
-0.44 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Gilead and Evolus is -0.44. Overlapping area represents the amount of risk that can be diversified away by holding Gilead Sciences and Evolus Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Evolus Inc and Gilead Sciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Gilead Sciences are associated (or correlated) with Evolus. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Evolus Inc has no effect on the direction of Gilead Sciences i.e., Gilead Sciences and Evolus go up and down completely randomly.
Pair Corralation between Gilead Sciences and Evolus
Given the investment horizon of 90 days Gilead Sciences is expected to generate 4.94 times less return on investment than Evolus. But when comparing it to its historical volatility, Gilead Sciences is 2.42 times less risky than Evolus. It trades about 0.03 of its potential returns per unit of risk. Evolus Inc is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 761.00 in Evolus Inc on August 30, 2024 and sell it today you would earn a total of 619.00 from holding Evolus Inc or generate 81.34% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Gilead Sciences vs. Evolus Inc
Performance |
| Timeline |
| Gilead Sciences |
| Evolus Inc |
Gilead Sciences and Evolus Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Gilead Sciences and Evolus
The main advantage of trading using opposite Gilead Sciences and Evolus positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Gilead Sciences position performs unexpectedly, Evolus can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evolus will offset losses from the drop in Evolus' long position.| Gilead Sciences vs. Ikena Oncology | Gilead Sciences vs. Eliem Therapeutics | Gilead Sciences vs. HCW Biologics | Gilead Sciences vs. RenovoRx |
| Evolus vs. Collegium Pharmaceutical | Evolus vs. Phibro Animal Health | Evolus vs. ANI Pharmaceuticals | Evolus vs. Procaps Group SA |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Other Complementary Tools
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |